• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
FRE

FIREBRICK PHARMA LIMITED - News & Media

3.90% ! 8.0¢
Market Cap $18.18M  !
Healthcare Biotechnology
Add to My Watchlist

Firebrick Pharma (ASX:FRE) is an Australian pharmaceutical developer focused on... Firebrick Pharma (ASX:FRE) is an Australian pharmaceutical developer focused on developing and commercializing novel formulations and uses of povidone-iodine. After more than 10 years of R&D including multiple human clinical trials, Firebrick's first product, Nasodine® Nasal Spray, is now available for sale in USA and Singapore.More

Corporate Spotlight

Firebrick Pharma (ASX:FRE) is an Australian pharmaceutical developer focused on developing and commercializing novel formulations and uses of povidone-iodine. After more than 10 years of R&D including multiple human clinical trials, Firebrick's first product, Nasodine® Nasal Spray, is now available
View the full Corporate Spotlight arrow Created with Sketch.

FIREBRICK PHARMA - JUNE INVESTOR WEBINAR

Articles & Videos

Study spruiks Firebrick's Nasodine spray as 'effective treatment for common cold'

A long-run study looking into leading Firebrick Pharma (ASX:FRE) product Nasodine has suggested the nasal spray can be an effective treatment for the common cold following a dive into the company’s Phase III trials.Listen to the HotCopper podcast for in-depth discussions and insig...

10 Jun 2025 10:07 (AEST)

'Expansion' the watchword in Firebrick's sales-heavy quarter

Firebrick Pharma Ltd has recorded a busy March quarter for 2025, marked by its move into retailing Nasodine in Singapore

16 Apr 2025 14:38 (AEST)

Invest in the Future of Healthcare – Firebrick Pharma’s Investor Webinar

"We have a moral, ethical obligation to make Nasodine available worldwide," - Firebrick Pharma founder & CEO, Dr Peter Molloy.

27 Feb 2025 15:46 (AEDT)

The world needs Nasodine: Here's why...

With the ongoing parade of pandemic threats, a tappable market for Firebrick Pharma's Nasodine isn’t going anywhere anytime soon.

21 Jan 2025 06:00 (AEDT)

History tells us there’ll be another pandemic. Given that, has Firebrick Pharma been wildly overlooked?

We live in a world that’s only just stopped reeling from the international COVID-19 viral pandemic.The same world where microbes and viruses are becoming ever-resistant to antibiotics and other treatments (and where mystery outbreaks and bird flu have come to the fore).And where @...

12 Dec 2024 08:51 (AEDT)

Firebrick Pharma launching retail Nasodine sales in Singapore

Firebrick Pharma (ASX:FRE) has inked a deal with Guardian, a pharmacy chain in Singapore, to launch retail sales of its Nasodine product.

25 Nov 2024 11:07 (AEDT)

Firebrick's Nasodine is now on sale in Singapore

Firebrick Pharma (ASX:FRE) has announced that its Nasodine® nasal spray product is now available in Singapore.

13 Jun 2024 09:04 (AEST)

Firebrick Pharma sees substantial holder up stake to 12% in placement

Betadine-like nasal spray provider Firebrick – whose flagship product has recently gone live for sale in the US – has raised $0.8M.

17 May 2024 10:27 (AEST)

Firebrick Pharma's US launch of Nasal Spray is nothing to be sneezed at

Australian pharmaceutical developer, Firebrick Pharma (ASX:FRE) has launched its latest product, Nasodine Nasal Spray, in the US market.

17 Apr 2024 14:40 (AEST)



Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
8.0¢ 		Change
0.003(3.90%) 		Mkt cap ! $18.18M
Open High Low Value Volume
7.7¢ 8.0¢ 7.7¢ $4.135K 51.75K

Buyers (Bids)

No. Vol. Price($)
1 9172 7.7¢
 

Sellers (Offers)

Price($) Vol. No.
8.3¢ 120000 1
View Market Depth
Last trade - 15.57pm 30/07/2025 (20 minute delay) ?
FRE (ASX) Chart

Top Stories

Ionic Rare Earths falls -7% as momentum slips on vague production update

Ionic Rare Earths (ASX:IXR) @ a well-known and much-loved rare earths darling on something of a comeback run lately @ has slipped -7%, presumably as the market digests what a vague update released on Wednesday actually means. According to the company, @urgent supply requests from US, European and...
ASX Market Close: Index rebounds as investors buoyant | July 30, 2025 The ASX200 rebounded today and was in the green heading into the close. Investors were buoyant in response to positive inflation data that increased the odds of an interest rate cut in August.Staples, Real Estate and Discretionary were the strongest performing sectors. Utilities and IT were a dra...
Neurizon inks $1.5M loan against R&D Tax Rebate Neurizon Therapeutics (ASX:NUZ) retreated in intra-day trade on Wednesday after inking a non-dilutive loan agreement for $1.5 million to fund its current and future operations seeking to treat Huntington’s with its flagship drug NUZ-001.The funds in question are secured against it...
Haranga jumps +7% on Lincoln acquisition Haranga Resources (ASX:HAR) has spiked in intra-day trade after closing the acquisition of the Lincoln Gold Project in California.The Lincoln Project traverses 322 hectares and covers a strike length of the Mother Lode with 5.8km between Sutter Creek and Amador City. It boasts a gold resource of ...
HotCopper Trends: Wall of quarterlies dominate; then there's Micro-X & Ionic Let’s check in with what HotCopper users are closely watching at lunchtime. Given that we’re basically on the deadline before companies get a scolding if they don’t report updates, on Wednesday, the ASX announcements list is basically one big wall o...
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.